NSE - Delayed Quote INR
NATCO Pharma Limited (NATCOPHARM.NS)
889.25
-13.60
(-1.51%)
At close: April 25 at 3:29:59 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
12,116,000
8,491,000
465,000
2,988,000
Investing Cash Flow
--
-10,327,000
-4,771,000
-53,000
-1,033,000
Financing Cash Flow
--
-2,469,000
-3,630,000
348,000
-1,857,000
End Cash Position
--
704,000
1,319,000
1,111,000
258,000
Capital Expenditure
--
-3,587,000
-2,056,000
-2,427,000
-2,546,000
Issuance of Capital Stock
--
--
--
--
1,000
Repayment of Debt
--
--
--
--
-484,000
Repurchase of Capital Stock
--
-2,537,000
-74,000
--
--
Free Cash Flow
--
8,529,000
6,435,000
-1,962,000
442,000
3/31/2021 - 1/1/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRREDDY.NS Dr. Reddy's Laboratories Limited
1,174.80
-2.14%
ZYDUSLIFE.NS Zydus Lifesciences Limited
859.65
-2.34%
LAURUSLABS.NS Laurus Labs Limited
625.65
-3.08%
DIVISLAB.NS Divi's Laboratories Limited
6,012.50
-3.27%
CIPLA.NS Cipla Limited
1,525.90
-1.66%
MOREPENLAB.NS Morepen Laboratories Limited
58.82
-5.46%
SUNPHARMA.NS Sun Pharmaceutical Industries Limited
1,787.40
-0.91%
LUPIN.NS Lupin Limited
2,019.60
-4.02%
SHILPAMED.NS Shilpa Medicare Limited
680.85
-5.67%
ZYDUSLIFE.BO Zydus Lifesciences Limited
859.10
-2.36%